Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

6.03
Delayed Data
As of Apr 24
 -0.375 / -5.85%
Today’s Change
3.10
Today|||52-Week Range
7.84
-20.24%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Progenics Pharmaceuticals Inc have a median target of 9.00, with a high estimate of 11.00 and a low estimate of 6.00. The median estimate represents a +49.25% increase from the last price of 6.03.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Progenics Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.16
Sales
$1.0M
Reporting Date
May 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 13.89%
 
 
 
 
 
 
Growthannually -983.33%
 
 
 
 
 
 

Sales

Growthquarterly 283.71%
 
 
 
 
 
 
Growthannually -64.34%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account